Subscribe To
Vertex pharmaceuticals (vrtx) increases yet falls behind market: what investors need to know
In the closing of the recent trading day, Vertex pharmaceuticals (VRTX) stood at $374, denoting a +0.81...
October 16, 2023, 7:33 pm
Amphastar pharmaceuticals (amph) laps the stock market: here's why
Amphastar pharmaceuticals (AMPH) closed at $46.47 in the latest trading session, marking a +1.55% move ...
October 16, 2023, 7:33 pm
Johnson & johnson (jnj) resumed the bearish cycle
Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged...
October 16, 2023, 4:23 pm
Oric pharmaceuticals, inc. (oric) upgraded to buy: what does it mean for the stock?
Oric Pharmaceuticals, Inc. (ORIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...
October 16, 2023, 1:32 pm
Terns pharmaceuticals announces global phase 1 clinical trial design of tern-701 for the treatment of chronic myeloid leukemia
Investigational New Drug application cleared by U.S. Food and Drug Administration Design leverages insights from partner’s ongoing Phase 1 trial in ...
October 16, 2023, 12:05 pm
Patrick j. mcenany, chairman and ceo of catalyst pharmaceuticals, receives prestigious 2023 lifetime achievement award from bioflorida
CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-s...
October 16, 2023, 12:03 pm
Pmv pharmaceuticals, inc. (pmvp) loses -70.19% in 4 weeks, here's why a trend reversal may be around the corner
The heavy selling pressure might have exhausted for PMV Pharmaceuticals, Inc. (PMVP) as it is technically in oversold territory now. In addition to th...
October 16, 2023, 11:18 am
Olema oncology announces phase 2 monotherapy clinical results to be presented at the 2023 esmo congress
Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor ...
October 16, 2023, 11:02 am
2 healthcare stocks near 52-week highs still worth buying
Healthcare stocks, on balance, haven't been great investments in 2023. Regeneron pharmaceuticals and Ve...
October 16, 2023, 9:26 am
Kiora pharmaceuticals to participate in the lytham partners fall 2023 investor conference
Encinitas, California--(Newsfile Corp. - October 16, 2023) - Kiora pharmaceuticals (NASDAQ: KPRX) invit...
October 16, 2023, 7:00 am
Vertex pharmaceuticals: one chart explains the mega rally
Vertex pharmaceuticals (VRTX) shares are climbing, up 28% in 2023. Consistent buy pressure is lifting t...
October 15, 2023, 8:49 am
Is vertex pharmaceuticals stock a buy now?
Vertex's sales have been slowing down, and this year the top line may rise by less than 10%. The company has multiple assets in phase 3 trials, which ...
October 15, 2023, 6:18 am
Infi monday deadline: rosen, leading investor counsel, encourages infinity pharmaceuticals, inc. investors to secure counsel before important october 16 deadline in securities class action – infi
NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Phar...
October 13, 2023, 8:45 pm
Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran
We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is ...
October 13, 2023, 6:11 pm
Processa pharmaceuticals to present at the thinkequity conference
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...
October 13, 2023, 5:08 pm
Syndax: biotech to watch with regulatory filings before end of 2023
Syndax Pharmaceuticals, Inc. reported positive results from its phase 1/2 trial using revumenib to treat relapsed/refractory leukemia patients. The tr...
October 13, 2023, 2:52 pm
Processa pharmaceuticals to present at the thinkequity conference
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage p...
October 13, 2023, 1:08 pm
: amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator
Amylyx pharmaceuticals Inc. AMLX shares fell 7.5% premarket on Friday after the company said the Europe...
October 13, 2023, 12:31 pm
Amylyx pharmaceuticals's als dug rejected again by eu regulators
Amylyx pharmaceuticals shares fell Friday after its ALS (amyotrophic lateral sclerosis) drug was denied...
October 13, 2023, 11:38 am
Eledon pharmaceuticals to present data from ongoing phase 1b trial of tegoprubart in patients undergoing kidney transplantation at the american society of nephrology kidney week 2023 annual meeting
IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will pr...
October 13, 2023, 11:00 am